Clover Corporation Limited (AU:CLV)
ASX:CLV
Want to see AU:CLV full AI Analyst Report?
CLV Stock Chart & Stats
AU$0.80
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.80
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.49 - AU$1.17
Previous CloseN/A
Volume30.13K
Average Volume (3M)223.73K
Market Cap
AU$146.96M
Enterprise ValueAU$137.95M
Total Cash (Recent Filing)AU$10.27M
Total Debt (Recent Filing)AU$1.26M
Price to Earnings (P/E)16.7
Beta0.04
Next Earnings
Sep 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.19%
Share Statistics
EPS (TTM)0.06
Shares Outstanding166,999,340
10 Day Avg. Volume49,116
30 Day Avg. Volume223,729
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.28
Price to Sales (P/S)1.08
P/FCF Ratio13.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$89.40M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & MarginsSustained top-line growth with materially improved gross and net margins indicates the business can expand without eroding profitability. Over the next 2–6 months this supports predictable earnings, funds reinvestment in product and capacity, and underpins durable operating leverage.
Conservative Balance SheetExtremely low leverage and a high equity ratio provide financial flexibility to fund growth or withstand downturns without refinancing stress. This capital structure preserves strategic optionality for capex, M&A or dividend policy across the medium term.
Cash Generation Relative To EarningsOperating cash conversion and free cash flow coverage of net income show the business converts earnings into cash at a reasonable rate. That cash backing supports reinvestment, working capital needs and shareholder returns over a multi-month horizon.
Bears Say
Declining Free Cash Flow GrowthA sharp decline in free cash flow growth signals potential issues with working capital, higher capex, or one-off cash items that reduce financial flexibility. If persistent, this can constrain reinvestment and shareholder returns despite healthy reported profits.
Moderate Return On EquityROE below double digits for a growing specialty manufacturer suggests limited capital efficiency versus peers. Over months this can limit surplus capital for strategic initiatives and make the company more dependent on operational improvement to lift long-term shareholder returns.
Small Scale And Concentration RiskLimited scale and a small employee base increase operational concentration and execution risk. Over the medium term, this can restrict distribution reach, bargaining power with large customers, and the ability to absorb disruptions or invest rapidly in new capabilities.
Clover Corporation Limited News
CLV FAQ
What was Clover Corporation Limited’s price range in the past 12 months?
Clover Corporation Limited lowest share price was AU$0.49 and its highest was AU$1.17 in the past 12 months.
What is Clover Corporation Limited’s market cap?
Clover Corporation Limited’s market cap is AU$146.96M.
When is Clover Corporation Limited’s upcoming earnings report date?
Clover Corporation Limited’s upcoming earnings report date is Sep 29, 2026 which is in 97 days.
How were Clover Corporation Limited’s earnings last quarter?
Clover Corporation Limited released its earnings results on Mar 23, 2026. The company reported AU$0.025 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.025.
Is Clover Corporation Limited overvalued?
According to Wall Street analysts Clover Corporation Limited’s price is currently Overvalued.
Does Clover Corporation Limited pay dividends?
Clover Corporation Limited pays a Semiannually dividend of AU$0.01 which represents an annual dividend yield of 2.19%. See more information on Clover Corporation Limited dividends here
What is Clover Corporation Limited’s EPS estimate?
Clover Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clover Corporation Limited have?
Clover Corporation Limited has 166,999,340 shares outstanding.
What happened to Clover Corporation Limited’s price movement after its last earnings report?
Clover Corporation Limited reported an EPS of AU$0.025 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 18.725%.
Which hedge fund is a major shareholder of Clover Corporation Limited?
Currently, no hedge funds are holding shares in AU:CLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Corporation Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.33%
12-Months-Change
Fundamentals
Return on Equity
12.22%
Trailing 12-Months
Asset Growth
6.81%
Trailing 12-Months
Company Description
Clover Corporation Limited
Clover Corporation Limited engages in the processing and worldwide sale of natural oils, reaching markets across Australia, New Zealand, Asia, Europe, and the Americas. The company's operations also encompass the creation of encapsulated products and extensive research and development focused on functional food and infant nutrition ingredients. Among its principal offerings are Nu-Mega Hi docosahexaenoic tuna oils, designed for use in infant formula and pharmaceutical goods, alongside its Ocean Gold refined tuna oils. Furthermore, it supplies Nu-Mega Driphorm powders, which are incorporated into various infant formulas, follow-on formulas, growing-up milks, and general food products, as well as Nu-Mega Driphorm HA for non-dairy applications. These products cater to several segments, including active living (for immune and sports support), healthy living (benefiting brain and heart health), and the foundational stages of infant and child development. The company, founded in 1988, maintains its corporate headquarters in Altona North, Australia.
Technical Analysis
Australian Dairy Nutritionals Group
―
Bubs Australia Ltd.
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---